For investors & inventors

From idea to IP
in one guided flow

Answer a few questions about your invention. We'll assess patentability, flag prior art risks, and match you with a qualified patent attorney.

Evaluate my idea → See how it works
JR
Jordan R. — MedTech founder
Idea submitted 2 days ago
Report ready
Novelty
74%
Non-obviousness
61%
Utility
90%
Sarah Chen, J.D. — Biotech / Drug delivery · Available this week
The process
01

Describe your idea

Plain language, no jargon required. Our structured intake guides you through what matters.

02

Get a novelty score

AI-assisted prior art scan across USPTO, EPO, and academic databases.

03

Review your report

A structured patentability summary with dimension scores and prior art flags.

04

Connect with counsel

Matched to USPTO-registered patent attorneys by tech category and budget.

Why PatentPath

Everything you need
before you file

Built for investors evaluating portfolio IP — and inventors who need clarity before spending on counsel.

Prior art scanning

We surface existing patents and publications that could affect your filing strategy before you pay an attorney to find them.

Patentability scoring

Structured novelty and non-obviousness assessment across four statutory dimensions — 35 U.S.C. §§ 101, 102, 103, 112.

Attorney matching

A curated network of patent attorneys organized by technology category, fee range, and availability. No cold calls.

Disclosure risk alerts

We flag public disclosure events that could start the 12-month statutory bar clock — before you inadvertently lose rights.

Timeline guidance

Understand provisional vs. non-provisional trade-offs and PCT filing windows based on your commercialization plans.

Confidential by default

All submissions are encrypted and never shared without your explicit consent. Attorney-client privilege attaches at connection.

Ready to protect your idea?

Free to start. No account required to see your score.

Evaluate my idea →
Not legal advice. PatentPath connects inventors with licensed patent counsel.